Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus

Rheumatology International

Volumn 33, Issue 2, 2013, Pages 511-516

  Karimifar, Mansoor ^a   Tahmasebi, Afshin ^a   Bonakdar, Zahra Sayed ^a   Purajam, Samaneh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyperprolactinaemia; The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)

Indexed keywords

PROLACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; IMMUNORADIOMETRIC ASSAY; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROLOGY; SLEDAI;

ADOLESCENT; ADULT; FEMALE; HUMANS; HYPERPROLACTINEMIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROLACTIN;

EID: 84873999091     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2211-5     Document Type: Article

References (51)

1. Mok CC, Lau CS, Tan SC (1997) Prolactin profile in a cohort of Chinese SLE patients. Br J Rheumatol 36:986-989
2. Huang CM, Chou CT (1997) Hyperprolactinemia in SLE. Chin Med J 59:37-41
3. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE (1991) Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 147:3780-3787
4. Walker SE, Jacobson JD (2000) Roles of prolactin and gonadotrophinreleasing hormone in rheumatic diseases. Rheum Dis Clin North Am 26:713-736
5. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR (1992) Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 303:222-226
6. Neidhart M (1996) Elevated serum prolactin or elevated prolactin/cortisol ratio are ssociated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 23:476-481
7. Allen SH, Sharp GC, Wang G et al (1996) Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5:30-37
8. Lavalle C, Loyo E, Paniagna R (1987) Correlation study between prolactin and androgen in male patients with SLE. J Rheumatol 14:268-272
9. Folomeev M, Prokaeva T, Nassonova V et al (1990) Prolactin level in man with SLE and RA (Letter). J Rheumatol 17:1569-1570
10. Jara-Quezada L, Graef A, Lavalle C (1999) Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 18:349-353
11. Jimena P, Aguirre MA, Lopez-Curbelo A, de Andres M, Garcia-Courtay C, Curado MJ (1998) Prolactin levels in patient with systemic lupus erythematosus: a case controlled study. Lupus 7(6):383-386
12. Buskila D, Lober M, Neumann L, Flusser D, Shoenfeld Y (1996) No correlation between prolactin level and clinical activity in patients with systemic lupis erythematosus. J Rheumatol 23(2):629-632
13. Mok CC, Lau CS, Lee KW, Wong RW (1998) Hyperprolactinemia in males with systemic lupus erythematosus. J Rheumatol 25(5):2357-2363
14. Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z et al (1997) Relationship between endocarine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 24(12):2330-2334
15. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 40:1725
16. Urowitz MB, Gladman DD, Tozman EC, Goldsmith CH (1984) The lupus activity criteria count (LACC). J Rheumatol 11:783-787
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
18. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669
19. Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523-1631
20. Berczi I (1992) The immunology of prolactin. Semin Reprod Endocrinol 10:196-219
21. Nagy E, Berczi I (1978) Immunodeficiency in hypo-physectomised rats. Acta Endocrinol (Copenh) 89:534-537
22. Nagy E, Berczi I, Nren GE et al (1983) Immunomodulation by bromocriptine. Immunopharmacology 6:231-243
23. Chuang E, Molitch ME (2007) Prolactin and autoimmune diseases in humans. Acta Biomed 8(1):255-261
24. Mukherjee P, Mastro AM, Hymer WC (1990) Prolactin induction of IL1 receptors on rat splenic lymphocytes. Endocrinology 126:88-94
25. Viselli SM, Stanek EM, Murherjee P et al (1991) Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129:983-990
26. Spangelo BL, Hall NRS, Ross PC et al (1987) Stimulation of in vitro antibody production and concanavalin A induced mouse spleen cell mitogenesis by prolactin. Int J Immunopharmacol 14:11-20
27. Russell DH, Kibler R, Matrisian L et al (1985) Prolactin receptors on human B and T lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134:3027-3031
28. Jacobi AM, Rohde W, Volk HD, Dörner T, Burmester GR, Hiepe F (2001) Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis 60(3):242-247
29. Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F (2001) Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol 28(7):1546-1553
30. Hartmann DP, Holaday JU, Bernton EW (1989) Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 3:2194-2202
31. Ben-Jonathan N, LaPensee CR, LaPensee EW (2008) What can we learn from rodents about prolactin in humans? Endocr Rev 29(1):1-41
32. McMurray R, Keisler D, Kondo K, Walker S (1994) Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71:338-343
33. McMurray R, Keisler D, Walker S (1990) Bromocriptine decreases early mortality in female NZB/W mice. Arthritis Rheum 33:R30
34. White A, Williams O (1988) Bromocriptine treatment suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 31:927-928
35. Palestine AG, Muellenberg-Coulombre CG, Kim MK et al (1987) Bromocriptine and low dose cyclosporine in the treatment of experimental uveitis in the rat. J Clin Invest 79:1076-1081
36. Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR (2003) Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol 30(10):2140-2146
37. Moszkorzová L, Lacinová Z, Marek J, Musilová L, Dohnalová A, Dostál C (2002) Hyperprolactinaemia in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20(6):807-812
38. Pasoto SG, Mendonça BB, Bonfá E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175-180
39. Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J (2001) Prolactin in human systemic lupus erythematosus. Lupus 10:748-756
40. Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R (2001) Elevated bioactive prolactin levels in systemic lupus erythematosus-association with disease activity. J Rheumatol 28(10):2216-2221
41. Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10(8):554-561
42. Gutiérrez MA, Molina JF, Jara LJ, García C, Gutiérrez-Ureña S, Cuéllar ML et al (1996) Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 109(3):229-235
43. Köller MD, Templ E, Riedl M, Clodi M, Wagner O, Smolen JS et al (2004) Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus. Ann Rheum Dis 63:1677-1680
44. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE (1994) Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 21(5):843-850
45. Petri M (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7(5):395-401
46. Vera-Lastra O, Jara LJ, Espinoza LR (2002) Prolactin and autoimmunity. Autoimmun Rev 1(6):360-364
47. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385-400
48. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8:25-30
49. McMurray RW, Weidensaul D, Allen SH, Walker SE (1995) Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 2:2084-2091
50. Pauzner R, Urowitz MR, Gladman DD, Gough JM (1994) Prolactin in systemic lupus erythematosus. J Rheumatol 11:2064-2067
51. Hattori N, Ikekwbo K, Ishihara T et al (1994) Effect of anti-prolactin autoantibodies on serum prolactin measurements. Eur J Endocrinol 130:434-437